nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelaic Acid—Leukoderma—Didanosine—acquired immunodeficiency syndrome	0.056	0.064	CcSEcCtD
Azelaic Acid—TYR—retina—acquired immunodeficiency syndrome	0.0339	0.273	CbGeAlD
Azelaic Acid—TYR—skin of body—acquired immunodeficiency syndrome	0.0298	0.24	CbGeAlD
Azelaic Acid—Tingling sensation—Didanosine—acquired immunodeficiency syndrome	0.0296	0.0338	CcSEcCtD
Azelaic Acid—Tingling sensation—Stavudine—acquired immunodeficiency syndrome	0.0257	0.0294	CcSEcCtD
Azelaic Acid—Acne—Stavudine—acquired immunodeficiency syndrome	0.0246	0.0281	CcSEcCtD
Azelaic Acid—TYR—lymphoid tissue—acquired immunodeficiency syndrome	0.0241	0.194	CbGeAlD
Azelaic Acid—TYR—blood—acquired immunodeficiency syndrome	0.0227	0.183	CbGeAlD
Azelaic Acid—Acne—Zidovudine—acquired immunodeficiency syndrome	0.0214	0.0244	CcSEcCtD
Azelaic Acid—Skin exfoliation—Nevirapine—acquired immunodeficiency syndrome	0.0204	0.0233	CcSEcCtD
Azelaic Acid—Tingling sensation—Delavirdine—acquired immunodeficiency syndrome	0.0188	0.0215	CcSEcCtD
Azelaic Acid—Acne—Ritonavir—acquired immunodeficiency syndrome	0.0166	0.019	CcSEcCtD
Azelaic Acid—Dermatitis contact—Indinavir—acquired immunodeficiency syndrome	0.0165	0.0189	CcSEcCtD
Azelaic Acid—Acne—Saquinavir—acquired immunodeficiency syndrome	0.016	0.0182	CcSEcCtD
Azelaic Acid—Acne—Lamivudine—acquired immunodeficiency syndrome	0.0152	0.0174	CcSEcCtD
Azelaic Acid—Skin exfoliation—Efavirenz—acquired immunodeficiency syndrome	0.0151	0.0172	CcSEcCtD
Azelaic Acid—Skin exfoliation—Delavirdine—acquired immunodeficiency syndrome	0.0144	0.0165	CcSEcCtD
Azelaic Acid—Dermatitis contact—Ritonavir—acquired immunodeficiency syndrome	0.0138	0.0158	CcSEcCtD
Azelaic Acid—Dry skin—Stavudine—acquired immunodeficiency syndrome	0.0138	0.0157	CcSEcCtD
Azelaic Acid—TYR—lymph node—acquired immunodeficiency syndrome	0.0136	0.11	CbGeAlD
Azelaic Acid—Dry skin—Indinavir—acquired immunodeficiency syndrome	0.0111	0.0127	CcSEcCtD
Azelaic Acid—Dry skin—Delavirdine—acquired immunodeficiency syndrome	0.0101	0.0115	CcSEcCtD
Azelaic Acid—Asthma—Efavirenz—acquired immunodeficiency syndrome	0.00991	0.0113	CcSEcCtD
Azelaic Acid—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00936	0.0107	CcSEcCtD
Azelaic Acid—Dry skin—Ritonavir—acquired immunodeficiency syndrome	0.0093	0.0106	CcSEcCtD
Azelaic Acid—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00907	0.0104	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Efavirenz—acquired immunodeficiency syndrome	0.00904	0.0103	CcSEcCtD
Azelaic Acid—Dry skin—Saquinavir—acquired immunodeficiency syndrome	0.00895	0.0102	CcSEcCtD
Azelaic Acid—Asthma—Ritonavir—acquired immunodeficiency syndrome	0.00877	0.01	CcSEcCtD
Azelaic Acid—Asthma—Saquinavir—acquired immunodeficiency syndrome	0.00844	0.00963	CcSEcCtD
Azelaic Acid—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.00837	0.00956	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Ritonavir—acquired immunodeficiency syndrome	0.008	0.00914	CcSEcCtD
Azelaic Acid—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00786	0.00897	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Saquinavir—acquired immunodeficiency syndrome	0.0077	0.00879	CcSEcCtD
Azelaic Acid—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00764	0.00872	CcSEcCtD
Azelaic Acid—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.00763	0.00871	CcSEcCtD
Azelaic Acid—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.0074	0.00845	CcSEcCtD
Azelaic Acid—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00727	0.0083	CcSEcCtD
Azelaic Acid—Pain—Didanosine—acquired immunodeficiency syndrome	0.00727	0.0083	CcSEcCtD
Azelaic Acid—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.0069	0.00788	CcSEcCtD
Azelaic Acid—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.00686	0.00783	CcSEcCtD
Azelaic Acid—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.00665	0.00759	CcSEcCtD
Azelaic Acid—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.00663	0.00756	CcSEcCtD
Azelaic Acid—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00661	0.00754	CcSEcCtD
Azelaic Acid—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.0066	0.00753	CcSEcCtD
Azelaic Acid—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00653	0.00746	CcSEcCtD
Azelaic Acid—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.00653	0.00745	CcSEcCtD
Azelaic Acid—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00641	0.00732	CcSEcCtD
Azelaic Acid—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00633	0.00723	CcSEcCtD
Azelaic Acid—Pain—Stavudine—acquired immunodeficiency syndrome	0.00631	0.0072	CcSEcCtD
Azelaic Acid—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00626	0.00715	CcSEcCtD
Azelaic Acid—Pain—Abacavir—acquired immunodeficiency syndrome	0.00622	0.0071	CcSEcCtD
Azelaic Acid—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00601	0.00686	CcSEcCtD
Azelaic Acid—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00596	0.00681	CcSEcCtD
Azelaic Acid—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00588	0.00671	CcSEcCtD
Azelaic Acid—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00588	0.00671	CcSEcCtD
Azelaic Acid—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00587	0.0067	CcSEcCtD
Azelaic Acid—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.00576	0.00657	CcSEcCtD
Azelaic Acid—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00563	0.00643	CcSEcCtD
Azelaic Acid—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00561	0.0064	CcSEcCtD
Azelaic Acid—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00548	0.00626	CcSEcCtD
Azelaic Acid—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00545	0.00622	CcSEcCtD
Azelaic Acid—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00544	0.00621	CcSEcCtD
Azelaic Acid—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00541	0.00617	CcSEcCtD
Azelaic Acid—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00539	0.00615	CcSEcCtD
Azelaic Acid—Rash—Didanosine—acquired immunodeficiency syndrome	0.00536	0.00612	CcSEcCtD
Azelaic Acid—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00536	0.00611	CcSEcCtD
Azelaic Acid—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00536	0.00611	CcSEcCtD
Azelaic Acid—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00535	0.00611	CcSEcCtD
Azelaic Acid—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00524	0.00598	CcSEcCtD
Azelaic Acid—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00522	0.00596	CcSEcCtD
Azelaic Acid—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00514	0.00587	CcSEcCtD
Azelaic Acid—Pain—Indinavir—acquired immunodeficiency syndrome	0.0051	0.00582	CcSEcCtD
Azelaic Acid—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00506	0.00578	CcSEcCtD
Azelaic Acid—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00499	0.00569	CcSEcCtD
Azelaic Acid—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00484	0.00553	CcSEcCtD
Azelaic Acid—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00482	0.0055	CcSEcCtD
Azelaic Acid—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00482	0.0055	CcSEcCtD
Azelaic Acid—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00481	0.0055	CcSEcCtD
Azelaic Acid—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.0048	0.00548	CcSEcCtD
Azelaic Acid—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00467	0.00533	CcSEcCtD
Azelaic Acid—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00466	0.00532	CcSEcCtD
Azelaic Acid—Rash—Stavudine—acquired immunodeficiency syndrome	0.00465	0.00531	CcSEcCtD
Azelaic Acid—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00465	0.00531	CcSEcCtD
Azelaic Acid—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00461	0.00526	CcSEcCtD
Azelaic Acid—Rash—Abacavir—acquired immunodeficiency syndrome	0.00458	0.00523	CcSEcCtD
Azelaic Acid—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00458	0.00523	CcSEcCtD
Azelaic Acid—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00458	0.00523	CcSEcCtD
Azelaic Acid—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00454	0.00518	CcSEcCtD
Azelaic Acid—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.00448	0.00511	CcSEcCtD
Azelaic Acid—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00439	0.00502	CcSEcCtD
Azelaic Acid—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00431	0.00492	CcSEcCtD
Azelaic Acid—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00426	0.00487	CcSEcCtD
Azelaic Acid—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00422	0.00482	CcSEcCtD
Azelaic Acid—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00415	0.00474	CcSEcCtD
Azelaic Acid—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00411	0.00469	CcSEcCtD
Azelaic Acid—Pain—Saquinavir—acquired immunodeficiency syndrome	0.0041	0.00468	CcSEcCtD
Azelaic Acid—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00404	0.00462	CcSEcCtD
Azelaic Acid—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00404	0.00461	CcSEcCtD
Azelaic Acid—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00399	0.00455	CcSEcCtD
Azelaic Acid—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00397	0.00453	CcSEcCtD
Azelaic Acid—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00391	0.00447	CcSEcCtD
Azelaic Acid—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00381	0.00435	CcSEcCtD
Azelaic Acid—Rash—Indinavir—acquired immunodeficiency syndrome	0.00376	0.00429	CcSEcCtD
Azelaic Acid—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00376	0.00429	CcSEcCtD
Azelaic Acid—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00367	0.00419	CcSEcCtD
Azelaic Acid—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00355	0.00406	CcSEcCtD
Azelaic Acid—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00355	0.00405	CcSEcCtD
Azelaic Acid—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00354	0.00404	CcSEcCtD
Azelaic Acid—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00353	0.00403	CcSEcCtD
Azelaic Acid—Rash—Delavirdine—acquired immunodeficiency syndrome	0.0034	0.00388	CcSEcCtD
Azelaic Acid—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.0034	0.00388	CcSEcCtD
Azelaic Acid—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.0034	0.00388	CcSEcCtD
Azelaic Acid—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00337	0.00385	CcSEcCtD
Azelaic Acid—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00324	0.0037	CcSEcCtD
Azelaic Acid—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00314	0.00359	CcSEcCtD
Azelaic Acid—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00314	0.00359	CcSEcCtD
Azelaic Acid—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00303	0.00345	CcSEcCtD
Azelaic Acid—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00302	0.00345	CcSEcCtD
Azelaic Acid—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00289	0.0033	CcSEcCtD
Azelaic Acid—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00288	0.00329	CcSEcCtD
